Topics

IONTAS Company Profile

10:21 EST 21st January 2020 | BioPortfolio


News Articles [13 Associated News Articles listed on BioPortfolio]

Adaptate and Iontas partner on antibody selection and optimization

Adaptate gains access to Iontasâ platform to select antibodies with optimal biophysical properties for the development of gamma delta T-cell modulating therapeutics.

Adaptate and Iontas’ partner on antibody selection and optimization

Adaptate gains access to Iontasâ platform to select antibodies with optimal biophysical properties for the development of gamma delta T-cell modulating therapeutics.

Teva, Iontas enter deal for biotherapeutics development

Teva Pharmaceuticals and Iontas have partnered to optimize human antibodies to be used for biotherapeutics.  -More- 

IONTAS Antibody Enters Clinical Trial for Use in the Treatment of B Cell Acute Lymphoblastic Leukemia

IONTAS Limited (IONTAS), a leader in the discovery and optimisation of fully human antibodies, has been informed that International Biotechnology Center (IBC) Generium, a leading Russian biopharmaceu...

IONTAS Announces New Antibody Optimisation Agreement With Teva Pharmaceuticals

IONTAS Limited (IONTAS), a leader in antibody discovery and optimisation of human monoclonal antibody libraries, today announced an agreement with Teva Pharmaceuticals (Teva) to apply its technologie...

IONTAS announces new antibody optimisation agreement with Teva Pharmaceuticals.

Cambridge, UK, 29 July 2019: IONTAS Limited (IONTAS), a leader in antibody discovery and optimisation of human monoclonal antibody libraries, today announced an agreement with Teva Pharmaceutical...

IONTAS antibody enters clinical trial for use in the treatment of B cell Acute Lymphoblastic Leukemia.

Cambridge, UK and Moscow, Russia, 09 December 2019: IONTAS Limited (IONTAS), a leader in the discovery and optimisation of fully human antibodies, has been informed that International Biotechnology ...

IONTAS and Adaptate Biotherapeutics Collaborate to Identify Optimised Antibodies for Novel Cancer Targets

  IONTAS Limited (IONTAS), a leader in the discovery and optimisation of fully human antibodies, today announced it has entered into a collaboration agreement with Adaptate Biotherapeutics, develop...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

More Information about "IONTAS" on BioPortfolio

We have published hundreds of IONTAS news stories on BioPortfolio along with dozens of IONTAS Clinical Trials and PubMed Articles about IONTAS for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of IONTAS Companies in our database. You can also find out about relevant IONTAS Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record